Regulatory Consulting Services USA — Expert FDA Regulatory Consulting
Specialist regulatory affairs consulting services for USA — covering FDA requirements and all major regulatory frameworks.
Regulatory consulting services USA companies rely on must combine deep FDA expertise with practical experience managing the full spectrum of American regulatory requirements — from drug and biologic submissions through to medical device 510(k) clearances and quality system compliance under 21 CFR. At RABT Global, our US regulatory consulting services are delivered by specialists who have guided pharmaceutical and medical device companies through the FDA regulatory process across every major product category.
Regulations & Requirements — USA
• 21 CFR Parts 210, 211 (pharma GMP)
• 21 CFR Part 820 (device QSR)
• 21 CFR Parts 807.40 (US Agent)
• FDCA and FD&C Act requirements
• ICH Q8, Q9, Q10 FDA alignments
Our USA Regulatory Consulting Services
FDA regulatory consulting services
NDA, ANDA, BLA, IND filing support
FDA submission consulting
510(k), PMA, De Novo device submissions
US regulatory affairs consultants for pharma and biotech
FDA compliance consulting services
GMP, QSR, 21 CFR Part 11
FDA regulatory support services
query response and inspection prep
US regulatory strategy consulting
market entry pathway planning
US Agent for FDA registration
tatutory US FDA Agent services
Regulatory Consulting Services in USA
RABT Global provides specialist regulatory consulting services in USA — covering pharmaceutical drug registration, medical device regulatory compliance, clinical trial applications, and ongoing regulatory lifecycle management under FDA regulatory requirements. Our USA regulatory consulting team combines in-country regulatory experience with global life sciences expertise to deliver effective, efficient regulatory programmes for every client.
USA Regulatory Consulting — FAQs
A: RABT Global’s FDA regulatory consulting services cover the full range of FDA submissions — including NDAs, ANDAs, BLAs, INDs, DMFs (pharma), and 510(k), PMA, De Novo, and IDE applications (medical devices). We also manage FDA Q-Submissions (pre-sub meetings), FDA annual reports, and post-approval supplements.
A: Yes. Our FDA regulatory support services include pre-inspection readiness programmes — covering document preparation, mock inspection, staff training, and CAPA verification. We have supported multiple clients in achieving successful FDA inspection outcomes across drug manufacturing and medical device quality system inspections.
A: RABT Global brings specialist FDA regulatory expertise combined with a global regulatory perspective. Our USA regulatory consulting services are delivered by dedicated in-country regulatory specialists — ensuring accurate, up-to-date guidance on all aspects of USA regulatory requirements for pharmaceutical and medical device companies.
Navigate USA Regulatory Requirements with Confidence
Expert regulatory consulting services for USA. FDA compliance. Market access. Delivered by RABT Global’s specialist USA regulatory team.